BMC Cancer
- HAO X, Xu L, Lan X, Li B, et al
Impact of hepatic inflammation and fibrosis on the recurrence and long-term
survival of hepatitis B virus-related hepatocellular carcinoma patients after
hepatectomy.
BMC Cancer. 2024;24:475.
BMC Gastroenterol
- KRANIDIOTI H, Zisimopoulos K, Oikonomou T, Voulgaris T, et al
Successful therapy with tenofovir disoproxil fumarate (TDF) in patients with
chronic hepatitis B (CHB) does not guarantee amelioration of liver damage
assessing by transient elastography. A retrospective - prospective multicenter
study.
BMC Gastroenterol. 2024;24:133.
Clin Res Hepatol Gastroenterol
- PATEL K, Twohig P, Peeraphatdit T, Stohs EJ, et al
Outcomes and factors associated with cryptococcal disease among cirrhotics: A
study of the national inpatient sample 2005 to 2014.
Clin Res Hepatol Gastroenterol. 2024;48:102337.
Dig Dis Sci
- MCCURDY H, Nobbe A, Scott D, Patton H, et al
Organizational and Implementation Factors Associated with Cirrhosis Care in the
Veterans Health Administration.
Dig Dis Sci. 2024 Apr 14. doi: 10.1007/s10620-024-08409.
- KHAMSEH ME, Malek M, Jahangiri S, Nobarani S, et al
Insulin Resistance/Sensitivity Measures as Screening Indicators of
Metabolic-Associated Fatty Liver Disease and Liver Fibrosis.
Dig Dis Sci. 2024;69:1430-1443.
- CON D, Tu S, Clayton-Chubb D, Lubel JS, et al
Effect of Concurrent Metabolic Dysfunction-Associated Steatotic Liver Disease on
Serial Non-invasive Fibrosis Markers in Chronic Hepatitis B.
Dig Dis Sci. 2024 Feb 20. doi: 10.1007/s10620-024-08354.
- WILLIAMS EE, Mladenovic A, Ranginani D, Weber R, et al
Role of Spleen Stiffness Measurement in the Evaluation of Metabolic
Dysfunction-Associated Steatotic Liver Disease.
Dig Dis Sci. 2024;69:1444-1453.
- BEHARI J
Spleen Stiffness Measurement in Metabolic Dysfunction-Associated Steatotic Liver
Disease-Value Added or Work in Progress?
Dig Dis Sci. 2024;69:1093-1095.
Gut
- LIU J, MacNaughtan J, Kerbert AJC, Portlock T, et al
Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbab
le, gut-restricted adsorbent in models and patients with cirrhosis.
Gut. 2024 Apr 15:gutjnl-2023-330699. doi: 10.1136/gutjnl-2023-330699.
Hepatology
- AJMERA V, Tesfai K, Sandoval E, Lopez S, et al
Validation of AGA clinical care pathway and AASLD practice guidance for
nonalcoholic fatty liver disease in a prospective cohort of patients with type 2
diabetes.
Hepatology. 2024;79:1098-1106.
- GISH RG, Wong RJ, Di Tanna GL, Kaushik A, et al
Association between hepatitis delta virus with liver morbidity and mortality: A
systematic literature review and meta-analysis.
Hepatology. 2023 Oct 23. doi: 10.1097/HEP.0000000000000642.
- SELLERS ZM, Assis DN, Paranjape SM, Sathe M, et al
Cystic fibrosis screening, evaluation and management of hepatobiliary disease
consensus recommendations.
Hepatology. 2023 Oct 26. doi: 10.1097/HEP.0000000000000646.
- PREMKUMAR M, Kajal K, Reddy KR, Izzy M, et al
Evaluation of terlipressin-related patient outcomes in hepatorenal syndrome-acute
kidney injury using point-of-care echocardiography.
Hepatology. 2023 Nov 17. doi: 10.1097/HEP.0000000000000691.
- GISH RG, Jacobson IM, Lim JK, Waters-Banker C, et al
Prevalence and characteristics of Hepatitis delta virus infection in patients
with hepatitis b in the united states: An analysis of the All-Payer Claims
Database.
Hepatology. 2023 Nov 17. doi: 10.1097/HEP.0000000000000687.
- DALBENI A, Lombardi R, Henrique M, Zoncape M, et al
Diagnostic accuracy of AGILE 3+ score for advanced fibrosis in patients with
NAFLD: A systematic review and meta-analysis.
Hepatology. 2024;79:1107-1116.
- DALBENI A, Mantovani A, Lombardi R, Ravaioli F, et al
Reply: Diagnostic accuracy of AGILE3+ score for advanced fibrosis in patients
with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Hepatology. 2024;79:E146-E147.
- LIU H, Li H, Wang DX, Li T, et al
Letter to the Editor: Diagnostic accuracy of AGILE 3+ score for advanced fibrosis
in patients with NAFLD: A systematic review and meta-analysis.
Hepatology. 2024;79:E144-E145.
- WIEGAND J, Franke A, Stein K, Trautwein C, et al
Letter to the Editor: Improving access to transient elastography data for
real-world prognostic applications in primary biliary cholangitis.
Hepatology. 2023 Dec 27. doi: 10.1097/HEP.0000000000000744.
- CORPECHOT C, Lemoinne S, Soret PA, Chazouilleres O, et al
Reply: Improving access to transient elastography data for Real-World Prognostic
Applications in primary biliary cholangitis.
Hepatology. 2023 Dec 27. doi: 10.1097/HEP.0000000000000746.
- VOLK ML
Innovations in Healthcare Delivery for Patients with Cirrhosis.
Hepatology. 2024 Apr 16. doi: 10.1097/HEP.0000000000000892.
- GARCIA-TSAO G, Kaplan DE
Reply: On the use of non-selective beta blockers in cirrhosis.
Hepatology. 2024 Apr 16. doi: 10.1097/HEP.0000000000000889.
- PRZYBYSZEWSKI EM, Bhan I, Yarze JC
Letter to the Editor: On the use of non-selective beta blockers in cirrhosis.
Hepatology. 2024 Apr 16. doi: 10.1097/HEP.0000000000000888.
- GUO C, Liu Z, Fan H, Wang H, et al
Machine learning-based plasma metabolomic profiles for predicting long-term
complications of cirrhosis.
Hepatology. 2024 Apr 17. doi: 10.1097/HEP.0000000000000879.
Intern Med
- HARA Y, Yanagita T, Ishii K, Nakamura K, et al
Portal Vein Thrombosis Caused by Miliary Tuberculosis.
Intern Med. 2024;63:1181-1182.
PLoS One
- CHAVEZ-TAPIA NC, Sanchez-Jimenez BA, Vidana-Perez D, Corrales-Rosas B, et al
Predictors for liver fibrosis in non-alcoholic patients with psoriatic diseases:
A multicenter cross sectional-study.
PLoS One. 2024;19:e0290632.
- GURUN M, Brennan P, Handjiev S, Khatib A, et al
Increased risk of chronic kidney disease and mortality in a cohort of people
diagnosed with metabolic dysfunction associated steatotic liver disease with
hepatic fibrosis.
PLoS One. 2024;19:e0299507.
- PASTROVIC F, Novak R, Grgurevic I, Hrkac S, et al
Serum proteomic profiling of patients with compensated advanced chronic liver
disease with and without clinically significant portal hypertension.
PLoS One. 2024;19:e0301416.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016